Skip to main content
Erschienen in: Neurological Sciences 9/2019

08.03.2019 | Letter to the Editor

Posterior reversible encephalopathy syndrome overlapping contrast-induced encephalopathy after coronary angiography

Erschienen in: Neurological Sciences | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Excerpt

Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiological disorder characterised by acute-onset neurological symptoms (typically seizures, encephalopathy, headache and visual disturbances) and reversible subcortical vasogenic brain oedema related to heterogeneous aetiologies. Brain imaging usually reveals vasogenic oedema predominantly involving the parieto-occipital regions. PRES is generally reversible, both radiologically and clinically [1]. On the other hand, contrast-induced encephalopathy (CE) has been described as a rare complication of angiography. It was first reported in 1970 as a transient cortical blindness and focal neurological deficits after coronary angiography (CAG) [2]. Clinical effects of neurotoxicity from iodinated contrast agents include visual fields defects, encephalopathy, seizures and focal neurological deficits. Also, CE is extensively reported to have a benign clinical course [2]. The reported incidence is 0.06% of patients undergoing CAG, 0.3–1% of patients undergoing vertebral angioplasty and 2.9% with endovascular coil treatment of posterior circulation aneurysm [2]. As already supposed, there is a clinical and neuroradiological overlap between the two syndromes [3]. Here, we report a case of typical PRES following CAG, and we discuss the pathophysiological overlap with CE. …
Literatur
1.
Zurück zum Zitat Fugate JE, Rabinstein AA (2015) Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 14:914–925CrossRefPubMed Fugate JE, Rabinstein AA (2015) Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 14:914–925CrossRefPubMed
2.
Zurück zum Zitat Leong S, Fanning NF (2012) Persistent neurological deficit from iodinated contrast encephalopathy following intracranial aneurysm coiling. a case report and review of the literature. Interv Neuroradiol 18:33–41CrossRefPubMedPubMedCentral Leong S, Fanning NF (2012) Persistent neurological deficit from iodinated contrast encephalopathy following intracranial aneurysm coiling. a case report and review of the literature. Interv Neuroradiol 18:33–41CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Saigal G, Bhatia R, Bhatia S, Wakhloo AKMR (2004) Findings of cortical blindness following cerebral angiography: is this entity related to posterior reversible leukoencephalopathy. Am J Neuroradiol 25:252–256PubMedPubMedCentral Saigal G, Bhatia R, Bhatia S, Wakhloo AKMR (2004) Findings of cortical blindness following cerebral angiography: is this entity related to posterior reversible leukoencephalopathy. Am J Neuroradiol 25:252–256PubMedPubMedCentral
4.
Zurück zum Zitat Granata G, Greco A, Iannella G, Granata M, Manno A, Savastano E, Magliulo G (2015) Posterior reversible encephalopathy syndrome--insight into pathogenesis, clinical variants and treatment approaches. Autoimmun Rev 14(9):830–836CrossRefPubMed Granata G, Greco A, Iannella G, Granata M, Manno A, Savastano E, Magliulo G (2015) Posterior reversible encephalopathy syndrome--insight into pathogenesis, clinical variants and treatment approaches. Autoimmun Rev 14(9):830–836CrossRefPubMed
5.
Zurück zum Zitat Ulas T, Buyukhatipoglu H, Dal MS, Kirhan I, Kaya Z, Demir ME, Tursun I, Eren MA, Aydogan T, Sezen Y, Aksoy N (2013) Urotensin-II and endothelin-I levels after contrast media administration in patients undergoing percutaneous coronary interventions. J Res Med Sci 18(3):205–209 Ulas T, Buyukhatipoglu H, Dal MS, Kirhan I, Kaya Z, Demir ME, Tursun I, Eren MA, Aydogan T, Sezen Y, Aksoy N (2013) Urotensin-II and endothelin-I levels after contrast media administration in patients undergoing percutaneous coronary interventions. J Res Med Sci 18(3):205–209
6.
Zurück zum Zitat Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N (2011) Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 10(7):618–625CrossRefPubMed Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N (2011) Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 10(7):618–625CrossRefPubMed
Metadaten
Titel
Posterior reversible encephalopathy syndrome overlapping contrast-induced encephalopathy after coronary angiography
Publikationsdatum
08.03.2019
Erschienen in
Neurological Sciences / Ausgabe 9/2019
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-019-03810-w

Weitere Artikel der Ausgabe 9/2019

Neurological Sciences 9/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.